Report
Bruno de La Rochebrochard

BLUELINEA: FY 2019 revenue/Capital Increase: A year of transition | CORPORATE | EUR8.8

BLUELINEA - CORPORATE | EUR8.8 (+76%)
FY 2019 revenue/Capital Increase: A year of transition

FY 2019 revenues: Affected as expected by the launch of new offers
Outlook: Strong Backlog and new contracts for a brighter future
Financial needs guaranteed to accelerate the group’s growth
Underlying
Bluelinea SA

Bluelinea S A. Bluelinea SA is a France-based company engaged in the medical sector. Bluelinea SA specializes in designing and developing electronic surveillance and medical teleassistance systems. It offers caregiver identification and authentication badges, individual protection bracelets for newborns, and home care and treatment devices for fragile or chronically ill elderly persons. The Company cooperates with Europe-based partners, including Everon Oy/Ab and Hager group, among others.

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Bruno de La Rochebrochard

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch